FGTI-2734 mesylate (1247018-19-4 free base) T11282L
The add to cart button will appear once you select the values above
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
FGTI-2734 mesylate can prevent membrane localization of KRAS, hence solving KRAS resistance problem and thwarting mutant KRAS patient-derived pancreatic tumors.�FGTI-2734 mesylate is a RAS C-terminal mimetic dual farnesyl transferase (FT) and geranylgeran
CAS nr:
T11282L
Purity:
98%
Molecular Weight:
606,73
SMILES:
OS(=O)(C)=O.O=S(C1=NC=CC=C1)(N(CCN(C2=CC=C(C#N)C=C2F)CC3=CN=CN3C)CC4CCCCC4)=O
Formula:
C27H35FN6O5S2
Pathway:
Others
Target:
Others